Fujitsu is partnering with a Japanese hospital on developing artificial intelligence (AI) technology for identifying pancreatic cancer on noncontrast CT exams.
The AI technology has been trained using data from 300 CT images of pancreatic cancer patients provided by Southern Tohoku General Hospital of Koriyama, Fukushima, Japan. It offers image analysis based on the shape of organs and tumors.
Fujitsu and Southern Tohoku plan to conduct clinical trials to further develop the AI technology for early diagnosis of this disease, Fujitsu said.
